
Initiate at Sell with a US$190 target as the share price outruns cash flow
We initiate on Palo Alto Networks at Sell with a US$190.31 target and −44% expected total return. It sells firewalls, cloud software, security operations and identity controls. Next-Generation Security annual recurring revenue (NGS ARR), active annualised cloud and artificial-intelligence (AI) subscriptions, reached US$9.7bn in FQ1 FY27, yet price outruns cash flow.
- Core growth slows to 14.5% in FY28E, half the 28% pace priced in. Fading emergency patching and the CyberArk lap explain US$41 a share of the gap to market expectations.
- Stock-based compensation (SBC), interest and tax cut FY27E cash flow in half to US$2.5bn. Ignoring SBC adds US$22 a share, while expensing it as cash cuts fair value to US$137.
- A 9.5% cost of equity leaves every scenario below the share price. Today’s price implies a 6.0% discount rate, and a 100bp rate rise cuts base value by US$21 a share.
What the market is missing. Standalone FY28E non-GAAP diluted earnings per share (EPS) reaches US$5.01, beating consensus. Applied Compute’s US$240m operating loss and 13.2m new shares pull consolidated EPS to US$4.72, 3% below the Street.
Catalysts. FQ2 FY27 results in February 2027 test recurring growth. Applied Compute closes in spring 2027 with 13.2m new shares, and August 2027 guidance tests the FY28 slowdown.
Valuation and target. Our 15-year discounted cash flow (DCF) gives US$162 a share, valuing free cash flow (FCF) before SBC and charging future grants via new shares. Cash-expensed SBC gives US$137 and peer enterprise value (EV) multiples give US$184. Weighting bear, base and bull gives US$174, rolling forward at 9.5% to our US$190 target.
Risks. An FQ2 FY27 ARR beat adds US$5 a share of upside, and faster AI compute scale adds US$2. Higher bond yields cut value by US$18 a share, and heavier stock grants cut US$11.
| Yr to 31 Jul, US$m | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Revenue | 9,221 | 11,480 | 14,694 | 17,074 | 19,600 |
| Growth y/y | 14.9% | 24.5% | 28.0% | 16.2% | 14.8% |
| Non-GAAP EBIT | 2,652 | 3,356 | 4,220 | 4,792 | 5,735 |
| Margin | 28.8% | 29.2% | 28.7% | 28.1% | 29.3% |
| GAAP net income | 1,134 | 307 | 827 | 963 | 1,754 |
| Non-GAAP EPS (US$) | 3.34 | 3.84 | 4.16 | 4.72 | 5.95 |
| Growth y/y | 17.6% | 15.0% | 8.4% | 13.4% | 26.1% |
| Free cash flow | 3,470 | 4,113 | 5,050 | 5,759 | 6,903 |
| At US$339.92, 18 Nov | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| P/E (non-GAAP) | 101.8x | 88.5x | 81.7x | 72.0x | 57.1x |
| EV / non-GAAP EBIT | 104.7x | 82.7x | 65.8x | 57.9x | 48.4x |
| P/B | 30.8x | 9.4x | 8.4x | 7.8x | 10.6x |
| FCF yield (per share) | 1.4% | 1.6% | 1.7% | 2.0% | 2.4% |
| Dividend yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| ROE (GAAP) | 17.5% | 1.7% | 2.7% | 2.7% | 5.4% |
| Net debt / EBIT | −3.2x | −1.8x | −2.6x | −3.4x | −1.4x |
| P/E at our target | 57.0x | 49.6x | 45.7x | 40.3x | 32.0x |
Source: Company filings (FY25A–FY26A); Yahoo Finance; Penmark Research model (FY27E–FY29E). Non-GAAP EBIT is the software EBITDA equivalent; multiples at US$339.92 except the final row.
Base value is US$162 a share, and even our US$253 bull case sits 26% below the price
Source: Yahoo Finance; Penmark Research model
FY30 NGS ARR tops US$20bn on +6pt higher platform growth. Margin reaches 41% and SBC falls to 5%.
Core growth fades from 14.5% in FY28E to 3.5% by FY41E. Margin reaches 38% and SBC falls to 7%, at a 9.5% cost of equity.
Emergency patching fades and platform growth runs 4pts lower. Margin stalls at 32% while SBC only falls to 12%.
| Income stmt, US$m | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Revenue | 9,221 | 11,480 | 14,694 | 17,074 | 19,600 |
| Non-GAAP EBIT | 2,652 | 3,356 | 4,220 | 4,792 | 5,735 |
| SBC-related charges | (1,386) | (1,712) | (2,278) | (2,561) | (2,842) |
| Intang., M&A & other | (23) | (949) | (1,340) | (1,200) | (1,059) |
| GAAP EBIT | 1,243 | 695 | 602 | 1,032 | 1,834 |
| Net interest & notes | 353 | (159) | 175 | 442 | 652 |
| Tax (expense)/ben. | (462) | (229) | 49 | (511) | (732) |
| GAAP net income | 1,134 | 307 | 827 | 963 | 1,754 |
| Cash flow, US$m | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| GAAP net income | 1,134 | 307 | 827 | 963 | 1,754 |
| Stock compensation | 1,295 | 1,774 | 2,278 | 2,561 | 2,842 |
| D&A and non-cash | 343 | 855 | 1,122 | 1,579 | 1,701 |
| Def. rev. & work. cap. | 944 | 1,617 | 1,419 | 1,809 | 1,919 |
| Operating cash flow | 3,716 | 4,553 | 5,645 | 6,912 | 8,216 |
| Capex (core & AI) | (246) | (440) | (595) | (1,153) | (1,313) |
| Free cash flow | 3,470 | 4,113 | 5,050 | 5,759 | 6,903 |
| Share repurchases | 0 | (1,000) | (500) | (500) | (15,362) |
| Balance sheet, US$m | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Cash & investments | 8,459 | 7,906 | 11,041 | 16,299 | 7,840 |
| Work. cap. ex def. rev. | 4,521 | 5,007 | 5,437 | 6,147 | 6,860 |
| Property & equip. | 387 | 523 | 800 | 1,454 | 2,066 |
| Goodwill & intang. | 5,330 | 29,027 | 31,907 | 30,827 | 29,827 |
| Total assets (net) | 21,890 | 46,284 | 53,463 | 59,005 | 50,871 |
| Deferred revenue | 12,752 | 14,756 | 16,604 | 19,123 | 21,756 |
| Net cash / (debt) | 8,459 | 6,132 | 11,041 | 16,299 | 7,840 |
| Shareholders’ equity | 7,824 | 27,492 | 34,596 | 37,620 | 26,853 |
| Per share & KPIs | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Diluted shares (m) | 709.0 | 764.0 | 850.1 | 865.0 | 836.8 |
| Non-GAAP EPS (US$) | 3.34 | 3.84 | 4.16 | 4.72 | 5.95 |
| Standalone EPS (US$) | 3.34 | 3.84 | 4.28 | 5.01 | 6.11 |
| GAAP EPS (US$) | 1.60 | 0.40 | 0.97 | 1.11 | 2.10 |
| FCF per share (US$) | 4.89 | 5.38 | 5.94 | 6.66 | 8.25 |
| Book value / sh (US$) | 11.04 | 35.98 | 40.69 | 43.49 | 32.09 |
| NGS ARR (US$m) | 5,580 | 9,100 | 11,603 | 13,923 | 16,429 |
| Core revenue (US$m) | 9,221 | 11,480 | 14,644 | 16,774 | 19,000 |
Source: Company 10-K filings (FY25A–FY26A); Penmark Research model (FY27E–FY29E). Shaded columns are estimates (E). Balance-sheet total assets are stated on the model’s operating-liabilities-netted basis; CyberArk 2029 convertible notes (US$1,774m at FY26A) settle in cash in FY27E.
Standalone FY27E sales beat consensus by 3%, yet consolidated FY28E EPS trails it by 3%
| Growth & margins | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Growth y/y | |||||
| Total revenue | 14.9% | 24.5% | 28.0% | 16.2% | 14.8% |
| Core revenue | 14.9% | 24.5% | 27.6% | 14.5% | 13.3% |
| Non-GAAP EBIT | 21.1% | 26.5% | 25.7% | 13.6% | 19.7% |
| Non-GAAP EPS | 17.6% | 15.0% | 8.4% | 13.4% | 26.1% |
| NGS ARR | 32.2% | 63.1% | 27.5% | 20.0% | 18.0% |
| Margins (% of revenue) | |||||
| Non-GAAP EBIT | 28.8% | 29.2% | 28.7% | 28.1% | 29.3% |
| GAAP EBIT | 13.5% | 6.1% | 4.1% | 6.0% | 9.4% |
| Adjusted FCF | 38.0% | 38.4% | 37.2% | 38.5% | 39.6% |
| FCF ex def. rev. | n.d. | n.d. | 21.8% | 19.0% | 21.8% |
| SBC % of revenue | 15.0% | 14.9% | 15.5% | 15.0% | 14.5% |
| Capex / sales | 2.7% | 3.8% | 4.1% | 6.8% | 6.7% |
| Returns & multiples | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Returns and leverage | |||||
| ROE (GAAP, avg) | 17.5% | 1.7% | 2.7% | 2.7% | 5.4% |
| ROA (GAAP, avg) | 5.3% | 0.9% | 1.7% | 1.7% | 3.2% |
| ROCE (non-GAAP) | n.m. | 32.4% | 18.8% | 21.4% | 28.4% |
| Net debt / equity | −108% | −22% | −32% | −43% | −29% |
| Net debt / EBIT | −3.2x | −1.8x | −2.6x | −3.4x | −1.4x |
| Valuation at US$339.92 | |||||
| P/E (non-GAAP) | 101.8x | 88.5x | 81.7x | 72.0x | 57.1x |
| EV / non-GAAP EBIT | 104.7x | 82.7x | 65.8x | 57.9x | 48.4x |
| P/B | 30.8x | 9.4x | 8.4x | 7.8x | 10.6x |
| FCF yield (EV) | 1.3% | 1.5% | 1.8% | 2.1% | 2.5% |
| Dividend yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| P/E at our target | 57.0x | 49.6x | 45.7x | 40.3x | 32.0x |
Source: Company filings; Penmark Research model. ROCE = non-GAAP EBIT / average invested capital (equity less net cash); FY25A invested capital was negative.
| US$m / US$/sh | 27E SA | 27E Grp | 28E SA | 28E Grp |
|---|---|---|---|---|
| Revenue (US$m) | ||||
| Penmark estimate | 14,644 | 14,694 | 16,774 | 17,074 |
| Consensus (pre-raise) | 14,160 | 14,160 | 16,230 | 16,230 |
| Prior-year period | 11,480 | 11,480 | 14,644 | 14,694 |
| Diff. vs consensus | +3.4% | +3.8% | +3.4% | +5.2% |
| Growth y/y (Penmark) | +27.6% | +28.0% | +14.5% | +16.2% |
| Non-GAAP diluted EPS (US$) | ||||
| Penmark estimate | 4.28 | 4.16 | 5.01 | 4.72 |
| Consensus (pre-raise) | 4.18 | 4.18 | 4.89 | 4.89 |
| Prior-year period | 3.84 | 3.84 | 4.28 | 4.16 |
| Diff. vs consensus | +2.4% | −0.4% | +2.5% | −3.5% |
| Growth y/y (Penmark) | +11.5% | +8.4% | +17.1% | +13.4% |
Source: LSEG/CNBC & StockAnalysis pre-results consensus (18 Nov 2026); Penmark Research model. SA = standalone; Grp = consolidated incl. Applied Compute. FQ2 FY27 guide: US$3,530m–US$3,550m sales, US$1.01–US$1.03 EPS.
Source: Company filings (A); LSEG/CNBC & StockAnalysis consensus; Penmark Research model (E)
At 65x trailing free cash flow, PANW trades at almost twice the peer multiple despite slower growth
| At current price | PANW | Peers | Diff. |
|---|---|---|---|
| Valuation | |||
| EV / LTM FCF | 65.1x | 34.4x | +89% |
| EV / LTM revenue | 22.3x | 11.0x | +103% |
| FCF yield (EV basis) | 1.5% | 2.9% | −1.4pp |
| Dividend yield | 0.0% | 0.0% | 0.0pp |
| Growth, cash & risk | |||
| Revenue growth* | 19.9% | 24.3% | −4.4pp |
| FCF margin (pre-SBC) | 34.3% | 29.8% | +4.5pp |
| SBC % of revenue | 15.6% | 20.7% | −5.1pp |
| FCF margin less SBC | 18.6% | 7.0% | +11.6pp |
| Net cash / EV | 2.6% | 5.6% | −3.0pp |
| Equity beta | 1.05x | 1.14x | −0.09x |
Source: Company filings; Penmark Research model. Peers (CRWD, FTNT, ZS, NET, OKTA) use 16 Nov 2026 closes, and PANW uses 18 Nov. *PANW growth compares the FY27 guidance midpoint with FY26 pro forma revenue adjusted for CyberArk only. Peer growth mixes reported LTM, nine-month and half-year bases. Peer median FCF margin less SBC is 7.0%, while the difference of medians is 9.1pp.
- Feb 27FQ2 FY27 results: NGS ARR vs US$10.20bn–US$10.22bn guide (+US$5.26/sh bull).
- Spr 27Applied Compute close: ~13.2m est. share issue and ~US$2.4bn est. capex start.
- Mid 27SASE agentic metering launch: monetises 9x y/y AI traffic (+US$1.52/sh).
- Aug 27Initial FY28 guidance: tests post-patching deceleration (−US$6.86/sh).
Source: Company calendar; Penmark Research model.
- Higher-for-longer rates. 5.10% 10Y yield compresses multiples. Prob. 40%; −US$17.54/sh.
- Persistent SBC dilution. FY28E stock pay runs 2pts higher near 17% of sales. Prob. 55%; −US$10.89/sh.
- Patching wave fades. Emergency AI budgets normalise in FY28. Prob. 40%; −US$6.86/sh.
- FQ2 FY27 ARR beat (upside). Beats US$10.22bn ARR guide. Prob. 60%; +US$5.26/sh.
Source: Penmark Research model.
Source: Company filings; Yahoo Finance monthly closes, Dec 2023 to Nov 2026; Penmark Research
Monthly EV/trailing FCF derived from monthly closes and reported period FCF, shares and net cash.
Source: Company filings; Yahoo Finance (peers 16 Nov 2026, PANW 18 Nov 2026); Penmark Research model
Six exhibits trace why US$9.7bn of NGS ARR still leaves 44% downside
Strong recurring bookings explain the rally, but ongoing share dilution and slowing growth cap intrinsic value. Granting every optimistic sell-side convention at once lifts base value only to US$264 a share, still US$76 below the share price.
Source: SEC Form 10-K/8-K filings and presentations; Yahoo Finance
Source: Company filings (FY26A); Penmark Research model (FY27E-FY41E)
Source: Penmark Research model, FY27E
Source: Penmark Research model (Market Check walk, US$/share)
Values in US$ per share.
Source: Company filings; Yahoo Finance monthly closes; Penmark Research model
Bands apply reference multiples to interpolated fiscal-year non-GAAP diluted EPS.
Source: Company filings; Penmark Research model
We sit below the market on all four debates, explaining about US$102 a share (57%) of the gap
Tested one at a time, four divides explain 57% of the US$178 gap to base value. Stacking all four lifts base value to US$264 a share, leaving an unexplained US$76 premium.
| Debate | Market view | Penmark view | Evidence | What changes our view | Resolves |
|---|---|---|---|---|---|
| Post-patching growth | Growth runs 4pts higher across FY28E–FY31E, worth US$203.11 a share; price implies 28.3%. | Core growth slows from 27.6% in FY27E to 14.5% in FY28E and 10.8% by FY31E: US$161.72, or −US$41.40. | Emergency AI patching lasts at least 18 months. CyberArk closed 11 Feb 2026 and laps in FQ3 FY27; guided pro forma growth is 19.9%. | Initial FY28 organic core growth guidance above 22%. | Aug 2027 |
| Discount rate | Cost of equity sits 100bp lower at 8.50%, worth US$190.75 a share; price implies 6.04%. | 9.50% cost of equity: 4.46% normalised risk-free rate (12-month average) plus 1.05 beta times 4.80% equity risk premium (−US$29.03 vs 8.50%). | US 10-year yield hit 5.10% on 17 Nov 2026, with 51.5% of EV in terminal value. Shares fell 23.0% from 27 Oct to 17 Nov. | Sustained 10-year yields below 3.5% with lower equity risk premiums. | Dec 2026–Mar 2027 |
| Stock compensation | Excluded from FCF with zero future dilution: US$183.77 a share Street upper bound. | Charged via dilution at US$338.40 for US$161.72 a share (−US$22.06), or US$137.41 as cash. | FY26A operating SBC was US$1,712m, or 14.9% of sales; FQ1 FY27 hit US$622m, or 18.1%, as shares rose 18%. | GAAP SBC charges below 10% of sales with shrinking diluted shares. | Sep 2027 |
| Long-term margin | Core non-GAAP margin reaches 41% at maturity (US$170.81/sh). | Core margin reaches 38% from FY38E (−US$9.10 vs 41%); Applied Compute dilutes near-term margin. | Standalone FY27E margin is flat at 29.5%. Applied Compute brings a US$240m FY28E loss and US$2,400m est. 4-yr capex. | FY28E non-GAAP margin above 31.5% with AI capex below US$1.5bn. | May–Aug 2027 |
Source: SEC filings; Federal Reserve; Penmark Research model (Market Check sheet). Per-share gaps show one-at-a-time shifts from US$161.72 base value.
Source: Penmark Research model (Market Check debates, one driver at a time)
How the debates map to our thesis chapters
Three chapters test these four divides. Our growth chapter tests Post-patching growth, worth US$41 a share, alongside Long-term margin, worth US$9 a share. Our cash-quality chapter tests Stock compensation, worth US$22 a share, and advance billings. Our valuation chapter tests Discount rate, where a 100bp cut adds US$29 a share.
Why consensus targets misprice PANW
Bulls apply high-growth multiples to headline FCF without charging stock pay. The US$399 average Street target capitalises adjusted FCF, guided at a 38% FY27 margin, while ignoring share dilution.
Source: Company calendar; Federal Reserve schedule; Penmark Research
Palo Alto Networks generated US$4.1bn of free cash flow in FY26 but only US$0.3bn of GAAP net income
Founded in 2005 to replace blind network firewalls, Palo Alto Networks now guards networks, clouds, security centres and identities for more than 70,000 organisations. Its consolidation model wins enterprise budgets, yet deferred revenue and employee stock grants disguise how little cash reaches each share.
The scene
In summer 2026, a major telecom carrier signed a US$126m deal with Palo Alto Networks across its network, identity vaults and security centre. PayPal signed a US$53m multi-product contract in the same quarter. Across the group, 78 accounts spend over US$10m a year on cloud and AI security, up 50% year on year.
What it actually does
Enterprises once stitched together dozens of point security tools. Palo Alto Networks sells three linked control planes: Network and AI Security covers firewalls and Secure Access Service Edge (SASE), Cortex automates security operations centres (SOCs), and Idira secures identities via CyberArk.
How the money comes in
Subscriptions and support supply 80% of sales under multi-year deals, and product adds 20%, with hardware near 10%. Of each US$1 of FY26A sales, 70¢ cleared delivery costs, yet only 6¢ survived as generally accepted accounting principles (GAAP) operating profit. Advance billings and working capital added US$1.6bn of cash and stock-based compensation added US$1.8bn, lifting free cash flow to 36¢ per dollar.
Where the story turns
Chief Executive Officer (CEO) Nikesh Arora arrived in June 2018 and turned a firewall vendor into a serial acquirer. In February 2024 he launched platformisation, granting free transition months to displace rivals. He closed CyberArk in February 2026, and on 18 November 2026 agreed to buy Applied Compute for US$4.5bn in stock. We expect the business to need about US$2.4bn of data-centre capex through FY30.
Why it works, and why it might not
Wiring firewall rules, SOC telemetry and privileged identities into one vendor makes switching painful. Platformised accounts post a 120% net retention rate (NRR), expanding spend by 20% net of churn. Valuation math breaks per-share returns: Post-patching growth cools once emergency AI upgrades and the CyberArk lap pass, while Stock compensation and AI capex dilute per-share cash.
Source: Channel, platform, retention and cash-retention unit economics from FY26A filings and FY27E model ratios (US$2,519m unlevered FCF after SBC on US$14,694m revenue).
Subscriptions generate 80% of FY26A revenue, yet acquisitions and stock pay consume GAAP profit
Source: FY26 Form 10-K; 2026 DEF 14A proxy; FQ4 FY26 presentation; FQ1 FY27 Form 8-K.
1 · Customers
2 · Offerings
3 · Streams
4 · Channels
5 · Cost to serve
6 · What is left
Source: FY26 Form 10-K; FQ4 FY26 presentation; FQ1 FY27 Form 8-K; Penmark Research model. Segment operating profit is n.d.
What Palo Alto Networks sells and why enterprises consolidate
Platformisation trades short-term discounting for multi-pillar lock-in across network, SOC and identity. Platformised accounts supply 65% of NGS ARR and retain 120% of prior-year spend. Segment operating profit is not disclosed.
How contracts are priced, billed and converted into cash
Revenue equals installed security modules multiplied by user, bandwidth or telemetry tiers. Multi-year contracts lift deferred revenue to 129% of FY26A sales and 113% in FY27E, pulling cash ahead of GAAP profit.
Of every US$1 of FY26A revenue, 56¢ goes to sales and R&D, leaving 6¢ in GAAP operating profit
Source: FY26 Form 10-K geographic note; FQ4 FY26 earnings presentation
Source: Audited FY26 Form 10-K income statement (US$m)
Fixed versus variable costs and limits on operating leverage
Cloud hosting, hardware build and support scale with volume, while R&D and sales carry heavy stock grants. FY26A gross margin reached 75.8% non-GAAP versus 70.4% GAAP. Sales and marketing took 34.2% of sales and R&D took 22.2%, holding GAAP operating margin to 6.1%.
Applied Compute adds physical data-centre fixed costs. Standalone FY27E non-GAAP margin holds at 29.5%, while Applied Compute’s losses pull consolidated FY28E margin to 28.1%.
Source: Penmark Research model (Revenue Build)
Idira growth is measured against FY26A pro forma revenue of US$1,260m.
Stock pay and working-capital inflows make up over 80% of FY26 free cash flow
Source: FY26 Form 10-K geographic note
Values in US$bn (FY26A total US$11,480m).
Regional mix and channel concentration
The Americas anchor two-thirds of sales, while distributors carry billing concentration. Americas revenue rose 24% in FY26A to US$7.7bn, with EMEA and APAC up 27% and 25%. Two distributors handled 30% of FY26A sales; single end-customer share is not disclosed.
Volume and price drivers inside platformised accounts
Expansion attaches SASE, XSIAM and Idira modules onto firewall estates. Net new platformisations rose from 60 in FQ1 FY26 to about 220 in FQ4 FY26, lifting accounts above US$10m NGS ARR to 78 and XSIAM sites to 1,000.
Source: Company quarterly filings and presentations; FQ4 FY26 deck; FQ1 FY27 Form 8-K
NGS ARR and Total RPO in US$bn; Large accts = customers above US$10m ARR.
Source: FY26 Form 10-K cash flow statement; Penmark Research model
Why cash outpaces earnings today and narrows tomorrow
Multi-year advance subscription billings keep generating deferred-revenue inflows while revenue grows, and shrink as growth slows. Revenue growth moderates from 28.0% in FY27E to 3.5% by FY41E. Deferred revenue eases from 129% of sales in FY26A to 108% from FY32E, narrowing working-capital tailwinds mechanically.
Global security spending grows 12%–17% into 2027, yet AI emergency budgets are cyclical
Enterprise security demand is expanding, though third-party series differ by scope. Gartner forecasts global information-security spend rising 11.6% to US$276bn in 2027, while International Data Corporation (IDC) projects a broader market rising 16.6% to US$362bn.
Source: Gartner and IDC public forecasts compiled Nov 2026
Gartner and IDC use distinct market definitions and forecast vintages.
Bottom-up market structure: seats, traffic and telemetry
Enterprise security spend equals protected identities, inspected network bandwidth and ingested security-log volume multiplied by annual tier pricing. Gartner placed 2026 end-user information-security spending at US$247bn, rising to US$276bn in 2027. Management estimates a 2030 TAM near US$340bn across network security, Cortex and Idira identity.
Source: FY26 Form 10-K; FQ4 FY26 presentation; Penmark Research
Demand drivers and cycle position
AI exploits opened emergency budgets in 2026, creating a temporary surge. Critical vulnerabilities jumped roughly sevenfold year on year and agentic traffic rose ninefold, sparking a patching wave of at least 18 months alongside a partial firewall refresh.
Concentration and market share
Cybersecurity stays fragmented, with PANW at 10.2% of cyber tech spend. Canalys/Omdia placed PANW first at 10.2% in calendar Q2 2025 across broad cyber technology rather than firewall or SASE alone. Gartner and IDC named PANW a 2026 Leader in Hybrid Mesh Firewall and SASE.
Who earns the industry margin
Software control-plane vendors earn 70%–80% gross margins, while cloud hosts and partners take fixed slices. Public clouds charge compute and egress fees, and distributors earn resale rebates without retaining recurring software rights.
Technology, regulatory and substitution threats
Bundled hyperscaler security and commoditising AI features cap pricing power. Microsoft bundles Defender and Sentinel into E5 licences, and management expects frontier AI defence to commoditise within two years, risking US$7 a share.
PANW leads peers on multi-pillar breadth at US$12.5bn of LTM sales, yet trails Fortinet by about 29pp on GAAP margin
Source: Company filings; Penmark Research model (Peers tab)
Source: Penmark Research assessment; Gartner and IDC 2026 reports; company filings
Qualitative capability scores reflect Penmark Research assessments informed by 2026 Gartner/IDC reports and GAAP filings.
| Pillar (FY26A rev.) | Primary rivals & substitutes | Customer buying criteria | PANW competitive rank & moat evidence |
|---|---|---|---|
| Network & AI (US$8,354m · 72.8%) |
Fortinet, Zscaler, Check Point, Cisco, Cloudflare, native cloud firewalls. | Zero-trust policy consistency across data centres, branches and AI agents. | Co-leader with Fortinet & Zscaler. Gartner & IDC 2026 Leader in Hybrid Mesh Firewall and SASE; US$1.6bn SASE ARR (+~40% y/y, FQ3 FY26). |
| Cortex SOC & Cloud (US$1,920m · 16.7%) |
CrowdStrike (Falcon Flex), Microsoft (Defender/Sentinel), SentinelOne, Splunk. | Mean time to detect/respond, telemetry ingestion cost, endpoint footprint. | Top-three challenger. XSIAM reached US$700m ARR (+70% y/y) and 1,000 accounts in FQ4 FY26, but faces fierce CrowdStrike Flex & Microsoft E5 bundling. |
| Idira Identity (US$614m · US$1,260m pro forma) |
Okta, Microsoft Entra, SailPoint, HashiCorp, BeyondTrust. | Privileged credential vaulting, secrets management for machine & AI identities. | Category leader in privileged access. CyberArk annual contract value (ACV) grew 27% y/y in FQ4 FY26 with immediate cross-sell into US$50m+ deals. |
| Applied Compute (US$0m · US$4.5bn deal) |
Hyperscaler AI studios, Databricks, Together AI, open-weight internal tooling. | Secure post-training and low-latency inference on proprietary enterprise data. | Unproven entrant. Pending FQ3 FY27 close; needs ~US$2,400m of modelled FY27E–FY30E capex outside PANW's historic software core. |
Source: FY26 Form 10-K competition disclosures; FQ4 FY26 presentation; FQ1 FY27 Form 8-K; Penmark Research assessment.
Evidence the switching-cost moat lasts, and its cost
Platformised accounts retain 120% of spend, yet buying that breadth depresses GAAP profitability. Ripping out firewall rules, XSIAM telemetry pipelines and CyberArk vaults together carries high operational risk, supporting durable retention. Free transition periods, CrowdStrike Flex rivalry and 15.6% LTM stock-based pay leave PANW at a 3.9% LTM GAAP operating margin against Fortinet’s 33.0%, a gap of about 29pp.
Source: Company filings; Penmark Research model (Peers & Historicals tabs)
LTM to Sep 2026 for Fortinet and to Oct 2026 for PANW; Fortinet non-GAAP equals GAAP plus 3.9% SBC.
Equity awards supply 94% of FY26 executive pay, while acquisitions absorbed 40% of five-year operating cash
| Executive | Tenure & background | How they are paid (FY26 reported) | What they own (at US$339.92) |
|---|---|---|---|
| Nikesh AroraChair & Chief Executive Officer | 8.4 yrs in roleChair & CEO since Jun 2018; 8.4 yrs at PANW. Prior: President & COO, SoftBank. | US$80.27m total, FY26 Salary US$1.00m; other US$2.33m; bonus US$1.00m; stock US$75.94m, or 94.6%. PSUs track NGS ARR, organic sales, margin & TSR. |
US$733.8m · 0.26%2.16m shares, or 734x base. Variable forward on up to 500k shares, 12 Oct 2026. |
| Dipak GolechhaEVP & Chief Financial Officer | 5.7 yrs in roleCFO since Mar 2021; met 5-yr hold rule Mar 2026. Prior: CFO, Nature's Bounty & Chobani; P&G. | US$21.82m total, FY26 Salary & other US$0.60m; bonus US$0.60m; stock US$20.62m, or 94.5%. Bonus tracks organic sales & margin. |
US$139.2m · 0.05%0.41m shares, or 232x US$0.60m base. Met 1x hold rule; no FY26 open-market buys. |
| William “BJ” JenkinsPresident | 5.3 yrs in rolePresident since Aug 2021; 5.3 yrs at PANW. Prior: CEO, Barracuda Networks; EMC. | US$22.13m total, FY26 Salary & other US$0.76m; bonus US$0.75m; stock US$20.62m, or 93.2%. Same corporate PSU & cash metrics. |
US$140.2m · 0.05%0.41m shares, or 187x US$0.75m base. Sold 56,214 shares for US$19.92m, 2–4 Nov 2026, via 10b5-1. |
| Lee KlarichEVP, Chief Product & Tech Officer; Director | 1.3 yrs in roleCPTO & Director since Aug 2025; 20.5 yrs at PANW since 2006. | US$13.83m total, FY26 Salary & other US$0.66m; bonus US$0.55m; stock US$12.63m, or 91.3%. Leads all three product pillars. |
US$365.1m · 0.13%1.07m shares, or 664x US$0.55m base. Met hold guideline May 2011. |
| Nir ZukFounder Emeritus, Former CTO | Co-founder, 2005Left CTO & executive role 14 Aug 2025 after 20 yrs at PANW. | US$6.44m total, FY26 Salary & other US$0.32m; bonus US$0; prior PSU value US$6.11m, no FY25 or FY26 grant. |
US$677.2m · 0.24%1.99m shares; base US$0 post-Aug 2025. Non-executive before 18 Sep 2026 record date. |
Source: 2026 Proxy Statement DEF 14A filed 27 Oct 2026 and Form 4 filings to 18 Nov 2026. Ownership at 18 Sep 2026 on 818.44m shares, valued at US$339.92 including options/units vesting in 60 days, excluding unvested PSUs. Current officers and directors ex Mr. Zuk hold 4.49m shares, or US$1,527.7m and 0.55%.
Does pay reward per-share value?
Pay rewards recurring scale and total shareholder return (TSR), not per-share dilution. Bonuses track organic sales and margin with a 10% responsibility modifier. Three-year performance stock units (PSUs) vest on NGS ARR and organic goals, with target TSR at the 55th percentile. Neither penalises FQ1 FY27’s 18% share-count rise or deal stock.
Governance, perks and insider hedging
Single-class voting is offset by a combined Chair-CEO, US$2.33m of perks and a 500,000-share collar. Average board tenure is eight years; Nikesh Arora chairs the board and Lee Klarich joined in August 2025. CEO perks included US$1.06m of security and US$0.93m of aircraft use. Mr. Arora collared up to 500,000 shares, or 23% of his stake, on 12 October 2026; Mr. Jenkins sold via 10b5-1.
Source: FY22-FY26 Forms 10-K; Penmark Research model (Historicals tab)
Consistent quarterly beats contrast with 46% share-count expansion and a capital-heavy pivot into AI compute
Source: FY22-FY26 Forms 10-K; Penmark Research model
Source: Company releases; Penmark Research model (Guidance tab)
Revenue and Next-Generation Security ARR in US$m; non-GAAP diluted EPS in US$.
| Capital use / deal | Timing & terms | Scale & funding | Economic return vs 9.5% cost of equity |
|---|---|---|---|
| CyberArk, Idira | Closed 11 Feb 2026 | Cash & stock; drove US$4,663m FY26A net cash M&A and lifted equity US$19.7bn | Sound fit, full price. Adds US$1,260m FY26A pro forma sales growing 20.6% in FY27E, plus US$1,774m of 2029 cash-settled notes. |
| Chronosphere | Closed FY26; ann. Nov 2025 | Within US$4,663m FY26A cash M&A and stock issue; standalone sales n.d. | Unverified return. Stock fell 7.4% on announcement; folded into Cortex and NGS without separate disclosure. |
| Applied Compute | Expected close FQ3 FY27 | US$4,500m stock, ~13.2m est. shares at 18 Nov close (ref. price n.d.) + US$2,400m modelled FY27E–30E capex (<US$3bn guide); ~US$500m cash/compute in | Near neutral at +US$0.91 a share vs 9.5% cost of equity. Losses in FY27E–29E on US$50m, US$300m and US$600m sales before 25% margin. |
| Share repurchases | FY22A–26A: US$2,732m; US$500m/yr FY27E–28E | US$1,000m in FY26A vs US$1,774m cash-flow SBC and US$1,712m operating SBC | Dilutive above value. Buying near US$340, over twice our US$162 base DCF, erodes value without halting dilution. |
| Core organic capex | FY22A–26A: US$1,182m | 2.7%–3.8% of sales, or US$440m in FY26A | High return at 32.4% FY26A non-GAAP ROCE. Cloud points of presence earned wide spreads, now diluted by AI capex. |
Source: FY22–FY26 Forms 10-K; FQ1 FY27 Form 8-K Ex. 99.2; Penmark Research model. Gross outlay and modelled capex total US$11.6bn before ~US$0.5bn of Applied Compute cash and compute received; CyberArk stock sits in FY26A’s US$19.7bn equity rise.
Why serial M&A changes the equity story
PANW is shifting from asset-light software into capital-heavy AI compute. Core capex took 7.3% of FY22A–FY26A operating cash, while cash M&A took 40.3% alongside stock deals. Applied Compute issues US$4.5bn of stock while bringing ~US$0.5bn of cash and prepaid compute. Management guided under US$3.0bn of capex, and we expect it to need about US$2.4bn through FY30, in a business where PANW has no incumbent moat.
What it means for per-share value
Dilution and AI losses explain why beats do not justify US$340. Diluted shares rose from 591m in FY22A to 764m in FY26A and reach 865m in FY28E, up 46% despite US$3.7bn of buybacks. Applied Compute adds +US$0.91 a share on DCF, yet cuts FY27E EPS by US$0.12 to US$4.16 and posts a US$240m FY28E operating loss.
Four drivers set the share price, and multiple expansion supplied 78% of the last year’s 69% gain
PANW trades on AI recurring momentum and sector multiple swings, not GAAP earnings. Across event days, return splits, 157-week regressions and 41 Q&A turns, four drivers pass at least two tests, and each prices more value than our DCF supports.
| Confirmed driver | What moves the stock | Tests passed | Market reaction vs our model value | Linked debate | Next number to watch |
|---|---|---|---|---|---|
| NGS ARR & platformisation | Net-new NGS ARR and full-year ARR guide raises. | 3 of 4 tests Events, returns, Q&A: 34.1% |
FQ1 FY27’s US$180m ARR beat lifted PANW 7.4% after hours to US$365.18, adding ~US$21.2bn on 838m shares after a 9.9% DHS/CISA rally. Repeat beat value: +US$5.26 a share. | Post-patching growth | FQ2 NGS ARR, Feb 2027: guide US$10.20–10.22bn; FY27E US$11.60bn. |
| AI threat & post-patching growth | AI patching urgency, XSIAM/AIRS & FY28+ organic pace. | 3 of 4 tests Events, returns, Q&A: 39.0% |
US$339.92 implies 28.3% FY28E core growth vs our 14.5% fade. That sits US$41.40 a share below a +4pt growth path, with a −US$6.86 bear fade risk. | Post-patching growth | Initial FY28 guide, Aug 2027: tests fade to 14.5% core growth. |
| M&A allocation & share dilution | Large stock/cash deals, SBC % of sales & share count. | 2 of 4 tests Events, Q&A: 19.5% |
CyberArk, Chronosphere and FQ4 FY26 drove 5%–9% drops on dilution fears. Charging SBC cuts DCF by US$22.06–46.36 a share, with a −US$10.89 bear risk. | Stock compensation | FQ3 Applied Compute close, May 2027: ~13.2m shares & capex ramp. |
| Sector multiple & discount rate | CIBR ETF multiple swings & equity risk appetite. | 3 of 4 tests Events, returns, R²: 71.1% |
Trailing P/E rose from 60.2x to 88.5x, pricing a 6.04% cost of equity vs our 9.50%. +100bp cuts base value US$21.35 a share; −100bp adds US$29.03. | Discount rate | 10Y yield & CIBR, Dec 2026 FOMC: 5.10% yield, 94bp spread. |
Source: Company filings & releases; earnings-call transcripts; Yahoo Finance; Penmark Research model. Confirmed drivers pass at least two of four empirical tests.
Source: Yahoo Finance next-session closes and 18 Nov 2026 after-hours print, FQ1 FY25 to FQ1 FY27
Source: Yahoo Finance; company filings; Penmark Research decomposition to 18 Nov 2026 (1Y Nasdaq-100 +10.7%; dividends 0%)
Sector factor moves explain 71% of weekly variance, while 93% of call Q&A targets AI, ARR and M&A
Source: Yahoo Finance weekly returns, n = 157, 24 Nov 2023 to 18 Nov 2026; Penmark Research OLS
Weekly 10-year Treasury yield changes add less than 0.1% incremental R-squared.
Source: Company earnings-call transcripts across FQ2 FY25 to FQ4 FY26, n = 41 analyst turns
What the market does
Bulls extrapolate AI beats. AI at 39% and NGS ARR at 34% lead Q&A. After 18 Nov’s 9.9% rally, FQ1 FY27’s US$180m ARR beat added 7.4%, or US$25.26, after hours.
What our model says
One beat adds US$5.26 a share, 79% below the jump. Core growth fades from 27.6% in FY27E to 14.5% in FY28E, half the 28.3% priced in.
Debate and next number
Links to Post-patching growth. Watch FQ2 FY27 NGS ARR in Feb 2027 vs the US$10.20bn–10.22bn guide, then FY28 guidance in Aug 2027.
What the market does
Dilution drew 20% of Q&A with hedged answers. CyberArk fell 5.2% and Chronosphere 7.4%; Applied Compute escaped on FQ1 FY27’s ARR beat.
What our model says
Charging SBC cuts value US$22.06–46.36 a share. Applied Compute issues ~13.2m shares and needs about US$2.4bn of capex on our estimate, cutting FY27E EPS US$0.12; SBC bear risk is US$10.89.
Debate and next number
Links to Stock compensation. Watch FQ3 FY27 Applied Compute close in May 2027 vs our 851m share base, plus FY27 SBC in Sep 2027.
What the market does
Market and sector explain 71.1% of weekly variance. A 1.47x CIBR slope drove 54pp of PANW’s 69% 1Y gain and Nov’s 23% drop.
What our model says
US$339.92 prices a 6.04% cost of equity, 94bp over 10Y yields. +100bp cuts value US$21.35 a share; rate bear risk is US$17.54.
Debate and next number
Links to Discount rate. Watch the Dec 2026 FOMC and peer EV/LTM FCF, where the 34.4x median sits near half PANW’s 65.1x.
Candidates tested and dropped: failed to pass two of four tests
What the market believes
Bulls extrapolate FQ1 FY27’s deal-boosted 39% revenue and 66% ARR growth. Consensus expects 14.6% FY28E growth, yet US$339.92 implies 28.3% FY28E core growth at a 9.5% cost of equity.
Three independent sources of evidence
- Pro forma math. Guided FY27 pro forma growth is 19.9%, adjusted for CyberArk while keeping Chronosphere. CyberArk booked US$614m in FY26A vs US$1,260m pro forma, so US$1,520m FY27E Idira sales is 20.6% organic, not 148%.
- Management’s patching clock. Nikesh Arora cited a 7x vulnerability spike driving at least 18 months of patching, before AI defence turns into a standard feature within two years.
- Peer checks. Guided 19.9% pro forma growth trails the 24.3% peer median, while CrowdStrike Falcon Flex above US$2.2bn ARR and Microsoft contest Cortex renewals.
Source: Penmark Research model (Revenue Build)
| US$m (except EPS & %) | FY27E | FY28E | FY29E | FY30E |
|---|---|---|---|---|
| Core revenue, Penmark | 14,644 | 16,774 | 19,000 | 21,288 |
| Core growth y/y | 27.6% | 14.5% | 13.3% | 12.0% |
| Consolidated revenue | 14,694 | 17,074 | 19,600 | 22,188 |
| Pre-raise consensus rev. | 14,160 | 16,230 | n.d. | n.d. |
| FY28E growth price needs | n.a. | 28.3% | n.a. | n.a. |
| Non-GAAP EPS, Penmark | US$4.16 | US$4.72 | US$5.95 | US$6.58 |
| Pre-raise consensus EPS | US$4.18 | US$4.89 | n.d. | n.d. |
| EPS gap vs consensus | −0.4% | −3.5% | n.a. | n.a. |
Source: LSEG/CNBC & StockAnalysis pre-results consensus; Penmark Research model. Standalone FY27E revenue of US$14,644m sits 3.4% above consensus and 0.7% above the raised guidance midpoint.
What it is worth
Post-patching fade is our largest operational debate, worth US$41.40 a share vs +4pt growth. Adding 2pts to FY28E–31E growth lifts base value from US$161.72 to US$181.41, and +4pts reaches US$203.11; adding a 41% margin reaches US$214.76. Bear air-pocket and 15% hardware risks cost US$6.86 and US$3.45.
Dated signposts
- Feb 2027, FQ2 FY27: NGS ARR vs US$10.20bn–10.22bn guide, up 61% with deals.
- May 2027, FQ3 FY27: First clean organic quarter past CyberArk’s 11 Feb 2026 close.
- Aug 2027, FY28 guide: Tests whether FY28 core growth cools toward 14.5%.
FY30E recurring revenue lands US$0.9bn shy of US$20bn on our US$2.4bn AI capex forecast
Source: FQ4 FY26 presentation; Penmark Research model
Source: FQ1 FY27 Form 8-K Ex. 99.2; Penmark Research model
Law of large numbers on the US$20bn ARR target
Reaching US$20.0bn of NGS ARR from US$9.10bn by FY30 needs US$2.7bn net-new each year. Bundles supply 65% of NGS ARR at 120% net retention across ~2,280 accounts at FQ3 FY26, with 78 above US$10m. We top raised FY27 guidance at US$11.60bn, up 27.5%, before growth slows to 20%, 18% and 16% in FY28E–30E, landing US$942m short at US$19.06bn.
Agentic SASE metering is incremental. Agentic traffic rose ~9x over the past year, with metering due in six to nine months, yet +1pt in FY28E Network and AI growth adds US$98m of sales and US$1.52 a share.
Applied Compute trades software margins for GPU capex
PANW has agreed to acquire Applied Compute for US$4.5bn in stock, issuing about 13.2m shares on our estimate at the 18 Nov close, since the reference price is not disclosed. Closing in FQ3 FY27, the deal brings ~US$500m of cash and prepaid compute; Applied Compute passed US$100m of annualised revenue within 18 months of founding, the company says.
Upfront capex and losses weigh on cash flow. Management set a US$1.0bn FY29 ARR ambition and a US$3.0bn capex ceiling; we model sales rising from US$50m in FY27E to US$900m in FY30E on US$2,400m of capex, with losses through FY29E (+US$240m FY29E sales adds US$2.47 a share).
What the market believes
The Street values PANW on adjusted FCF without charging stock pay. Guidance is 38.0% FY27 adjusted FCF margin, or ~US$5.58bn; we model 37.2%, or US$5.47bn. Both and our US$2.52bn unlevered FCF after SBC include US$1,848m of deferred-revenue inflows and Applied Compute’s loss. The US$2.95bn gap deducts US$2,278m of SBC, US$253m of interest/tax, US$220m of acquisition-related costs and US$200m of Applied Compute data-centre capex.
Three independent sources of evidence
- Audited cash split. FY26A GAAP net income was US$307m after US$1,712m of operating SBC, while FCF hit US$4,113m via US$1,774m of cash-flow SBC (15.5% of sales), US$855m of depreciation and amortisation, and US$1,617m of deferred revenue/working capital. Deferred revenue eases from 129% in FY26A to 113% in FY27E and 108% by FY32E.
- FQ1 FY27 dilution. FQ1 FY27 SBC reached US$622m, or 18.1% of sales, as diluted shares rose 18% to 838m; we model 844.6m standalone FY27E shares and 851.2m with 13.24m Applied Compute shares.
- Fortinet proof. Fortinet posted a 43.5% LTM FCF margin on 3.9% SBC, earning a 33.0% LTM GAAP margin vs PANW’s 3.9% on 15.6% LTM SBC, a ~29pp gap.
Source: Penmark Research model (Financials & Valuation tabs)
Source: Penmark Research model (Valuation & Market Check tabs)
What it is worth
Employee equity cuts base value by US$22.06–46.36 a share, yet zero SBC still leaves 45.9% downside. Dropping SBC lifts base value to US$183.77 and our target to US$216.27, still a Sell. Holding deferred revenue at 113% adds US$1.85 to US$163.57, while treating prepayments as debt cuts base value to US$86.37. If FY28E SBC runs 2pts higher near 17%, bear dilution costs US$10.89 a share.
Dated signposts
- May 2027, FQ3 FY27: Final Applied Compute share count vs 13.24m modelled, plus any bolt-on deals such as reported US$0.5bn Clutch talks.
- Sep 2027, FY27 10-K: Full-year SBC vs FY26A’s 14.9% operating rate and deferred revenue vs 113%.
What the market believes
With 44 Buys, zero Sells and a US$398.63 mean target, the Street prices PANW as rate-immune. At US$339.92, PANW trades at 65.1x EV/LTM FCF and 72.0x FY28E EPS, an 89% FCF multiple premium over peers growing 4.4pp faster.
Three independent sources of evidence
- Reverse-DCF check. US$339.92 needs a 6.04% cost of equity, 94bp above 5.10% 10-year yields, or 7.96% terminal growth, or 28.3% FY28E core growth.
- Generosity walk. Zero SBC, 9.0% cost of equity, 4.0% terminal growth, faster growth, a 41% margin and flat deferred revenue reach US$263.58, still US$76.34 short.
- Drawdown history. At a 1.47x CIBR beta, PANW fell 29.5% to 24 Feb 2026 and 23.0% from 27 Oct to US$309.29 on 17 Nov, including −9.6% on 5 Nov after Fortinet’s slowdown.
Source: Penmark Research model (Market Check reverse DCF)
Source: Yahoo Finance daily closes, 18 Nov 2025 to 18 Nov 2026
Series shows daily drawdown vs rolling closing peak; only the 18 Nov point (−19%) is measured against 6 Oct's US$419.91 high.
What it is worth
+100bp cuts base value US$21.35 to US$140.37 a share; −100bp adds US$29.03. Peer-median 34.4x EV/LTM FCF plus net cash yields US$183.95, 45.9% below US$339.92. A 10% rate-led peer multiple drop is our largest bear hit at US$17.54 a share.
Dated signposts
- Dec 2026 & Mar 2027, FOMC: Rate path vs 5.10% 10-year Treasury yield.
- 1 Dec 2026, CrowdStrike FQ3 FY27: Tests whether 18 Nov’s 6%–12% sector jump holds.
- Aug 2027, FY28 outlook: Mid-teens organic growth compresses PANW toward peers.
Four years of 20% compound sales growth rest on widening GAAP adjustments and deferred-revenue inflows
| US$m unless stated (fiscal year to 31 July) | FY22A | FY23A | FY24A | FY25A | FY26A | FY27E |
|---|---|---|---|---|---|---|
| Growth, profitability and GAAP-to-non-GAAP bridge | ||||||
| Revenue | 5,502 | 6,893 | 8,027 | 9,221 | 11,480 | 14,694 |
| Revenue growth, y/y (%) | n.d. | 25.3% | 16.5% | 14.9% | 24.5% | 28.0% |
| Gross profit (GAAP) | 3,783 | 4,983 | 5,968 | 6,770 | 8,077 | n.d. |
| GAAP gross margin (%) | 68.8% | 72.3% | 74.3% | 73.4% | 70.4% | n.d. |
| Non-GAAP operating income | n.d. | 1,660 | 2,190 | 2,652 | 3,356 | 4,220 |
| Non-GAAP operating margin (%) | n.d. | 24.1% | 27.3% | 28.8% | 29.2% | 28.7% |
| Less: SBC-related charges (deck basis) | n.d. | (1,145) | (1,162) | (1,386) | (1,712) | (2,278) |
| Less: intangible amort., acquisition & other items | n.d. | (128) | (344) | (23) | (949) | (1,340) |
| GAAP operating income | (189) | 387 | 684 | 1,243 | 695 | 602 |
| GAAP operating margin (%) | −3.4% | 5.6% | 8.5% | 13.5% | 6.1% | 4.1% |
| GAAP net income | (267) | 440 | 2,578 | 1,134 | 307 | 827 |
| Cash conversion, stock compensation and share count | ||||||
| Net cash from operating activities | 1,985 | 2,778 | 3,258 | 3,716 | 4,553 | 5,645 |
| Stock-based compensation (cash-flow statement) | 1,011 | 1,075 | 1,075 | 1,295 | 1,774 | 2,278 |
| Free cash flow (OCF less capex) | 1,792 | 2,631 | 3,101 | 3,470 | 4,113 | 5,050 |
| Free cash flow margin (%) / Adjusted FCF (US$m) | 32.6% / n.d. | 38.2% / 2,671 | 38.6% / 3,121 | 37.6% / 3,507 | 35.8% / 4,414 | 34.4% / 5,470 |
| Weighted-average diluted shares (m, split-adjusted) | 591.0 | 684.6 | 708.0 | 709.0 | 764.0 | 850.1 |
Source: Audited FY22–FY26 Forms 10-K; FQ4 FY26 earnings presentation (1 Sep 2026); Penmark Research model. Note: Non-SBC line combines intangible amortisation/deal costs (US$123m, US$132m, US$54m and US$933m in FY23A–FY26A) with other GAAP items (−US$5m, −US$212m, +US$31m and −US$16m); FY24A GAAP net income includes a US$1,590m tax valuation-allowance release.
Source: FY23-FY26 Forms 10-K; FQ4 FY26 deck; Penmark Research model
Growth split: software mix vs M&A step-ups
Sales grew 20.2% a year in FY22A–26A, with M&A driving FY26A. Subscriptions hit US$9,200m, or 80.1%; product was US$2,280m (~10% hardware). Growth slowed from 25.3% in FY23A to 14.9% in FY25A before 24.5% in FY26A (17.8% ex US$614m of Idira post-11 Feb 2026; Chronosphere n.d.).
Accounting choices that flatter headline metrics
- SBC add-back. US$1,712m of SBC drove 14.9pp of the 23.1pp FY26A gap (6.1% vs 29.2%), with 8.2pp from deal/amortisation items; FQ1 FY27 SBC hit US$622m, or 18.1%.
- Commissions & financing. Deferred contract costs rose from US$1,005m to US$1,211m in FY26A alongside US$1,397m of financing receivables.
- FCF add-backs. US$4,414m FY26A adjusted FCF adds US$301m above US$4,113m FCF and will exclude ~US$2.4bn of modelled Applied Compute capex.
- Tax & note marks. FY24A’s US$2,578m profit held a US$1,590m tax release; US$1,930m of 2029 notes at 31 Oct 2026 swing GAAP earnings.
Standalone FY27E revenue beats raised guidance by about US$100m before core growth slows to about 15% in FY28E
Source: FQ4 FY26 earnings presentation (FY26A); Penmark Research model (Revenue Build, FY27E-FY31E)
| US$m unless stated | FY26A | FY27E | FY28E | FY29E | FY30E | FY31E |
|---|---|---|---|---|---|---|
| Network & AI Security | 8,354 | 9,816 | 10,994 | 12,203 | 13,424 | 14,632 |
| Growth, y/y (%) | 17.2% | 17.5% | 12.0% | 11.0% | 10.0% | 9.0% |
| Cortex (XSIAM, XDR, Cloud & Chronosphere) | 1,920 | 2,669 | 3,309 | 4,004 | 4,725 | 5,481 |
| Growth, y/y (%) | 24.8% | 39.0% | 24.0% | 21.0% | 18.0% | 16.0% |
| Idira, identity security (FY26A pro forma: US$1,260m) | 614 | 1,520 | 1,794 | 2,081 | 2,393 | 2,704 |
| Organic / pro forma growth, y/y (%) | 21.2% | 20.6% | 18.0% | 16.0% | 15.0% | 13.0% |
| Other (Unit 42, services & financing) | 592 | 639 | 678 | 712 | 747 | 777 |
| Core platform revenue | 11,480 | 14,644 | 16,774 | 19,000 | 21,288 | 23,593 |
| Core platform growth, y/y (%) | 24.5% | 27.6% | 14.5% | 13.3% | 12.0% | 10.8% |
| Applied Compute (open-weight AI models) | n.a. | 50 | 300 | 600 | 900 | 1,150 |
| Total consolidated revenue | 11,480 | 14,694 | 17,074 | 19,600 | 22,188 | 24,743 |
| Total consolidated growth, y/y (%) | 24.5% | 28.0% | 16.2% | 14.8% | 13.2% | 11.5% |
| Memo: Next-Generation Security ARR (year-end) | 9,100 | 11,603 | 13,923 | 16,429 | 19,058 | n.d. |
| NGS ARR growth, y/y (%) | 63.1% | 27.5% | 20.0% | 18.0% | 16.0% | n.d. |
Source: FQ4 FY26 earnings presentation (1 Sep 2026); Penmark Research model (Revenue Build). Core revenue fades linearly from 10.8% in FY31E to 3.5% in FY41E.
| Metric & period | Guidance | Consensus | Penmark | Reason for gap |
|---|---|---|---|---|
| FY27E standalone rev. (US$m) | 14,520–14,570 | 14,160 | 14,644 | +US$99m vs midpoint after +4.2% FQ1 beat; Street pre-raise |
| FY27E NGS ARR (US$m) | 11,475–11,525 | n.d. | 11,603 | +US$103m vs midpoint; FQ1 US$9.73bn beat by US$180m |
| FY27E non-GAAP EPS (US$) | 4.26–4.30 SA | 4.18 | 4.28 SA / 4.16 | Matches midpoint; US$100m AI loss & +5.6m shares cut US$0.12 |
| FY27E adj. FCF margin (%) | 38.0% | n.d. | 37.2% | Within 100bp; FCF before add-backs is 34.4%, or US$5,050m |
| FY28E consol. rev. (US$m) | n.d. | 16,230 | 17,074 | +5.2% vs Street: US$16,774m core (+14.5%) + US$300m AI |
| FY28E non-GAAP EPS (US$) | n.d. | 4.89 | 4.72 | −3.5% vs Street: US$5.01 SA less US$240m loss & 13.2m shares |
| FY30E ARR / FY29E AI (US$m) | 20,000 / 1,000 | n.d. | 19,058 / 600 | 4.7% shy of FY30 ARR goal; prudent Applied Compute ramp |
Source: FQ1 FY27 Form 8-K Ex. 99.1 (18 Nov 2026); LSEG/CNBC & StockAnalysis consensus (18 Nov 2026 pre-raise); Penmark Research model. SA = standalone ex Applied Compute.
Even 4pts faster annual growth with a 41% long-run margin caps base value at US$215 a share
Source: Penmark Research model (Revenue Build)
Source: Penmark Research model (Sensitivities tab)
Values in US$ per share.
| Margins, cash conversion, capex & balance sheet (US$m) | FY26A | FY27E | FY28E | FY29E | FY30E | FY31E |
|---|---|---|---|---|---|---|
| Core non-GAAP operating income / margin (%) | 3,356 / 29.2% | 4,320 / 29.5% | 5,032 / 30.0% | 5,795 / 30.5% | 6,599 / 31.0% | 7,491 / 31.8% |
| Applied Compute operating income / margin (%) | n.a. | (100) / −200% | (240) / −80% | (60) / −10% | 90 / 10% | 230 / 20% |
| Consolidated non-GAAP EBIT / margin (%) | 3,356 / 29.2% | 4,220 / 28.7% | 4,792 / 28.1% | 5,735 / 29.3% | 6,689 / 30.1% | 7,721 / 31.2% |
| SBC-related charges / % of revenue | 1,712 / 14.9% | 2,278 / 15.5% | 2,561 / 15.0% | 2,842 / 14.5% | 3,106 / 14.0% | 3,217 / 13.0% |
| Change in deferred revenue (cash inflow) | n.d. | 1,848 | 2,519 | 2,632 | 2,652 | 2,563 |
| Capital expenditure: Core / Applied Compute | (440) / n.a. | (395) / (200) | (453) / (700) | (513) / (800) | (575) / (700) | (637) / (345) |
| Unlevered free cash flow after SBC / margin (%) | n.a. | 2,519 / 17.1% | 2,844 / 16.7% | 3,546 / 18.1% | 4,355 / 19.6% | 5,209 / 21.1% |
| Year-end cash & investments (after note payoff & buybacks) | 7,906 | 11,041 | 16,299 | 7,840 | 8,875 | 9,897 |
Source: Penmark Research model (Financials and Valuation tabs). FY26A standalone deferred-revenue cash change is n.d. (combined deferred revenue, working capital & non-cash items = +US$1,617m). Core margin reaches 38.0% and SBC reaches 7.0% from FY38E.
Platform mix shift and fixed-vs-variable cost leverage
Software platforms lift core margins to 38.0% long term, while Applied Compute trims FY27E–28E group margins. Variable cloud, support and appliance costs stay near 24% of core sales, letting R&D and sales scale core margins up 50–100bp a year. Applied Compute posts losses of US$100m in FY27E and US$240m in FY28E, inside guided 100bp and 200bp drags, before reaching 25% from FY32E.
Working capital, GPU capex and balance-sheet path
Deferred-revenue inflows peak in FY28E, while ~US$2.4bn of modelled AI capex absorbs cash. Deferred revenue eases from 113% of sales in FY27E to 108% from FY32E, pulling inflows from 12.6% of sales to 3.7% as growth slows to 3.5% by FY41E. We model US$2,400m of FY27E–30E Applied Compute capex, under the US$3.0bn ceiling. FY27E settles US$1,915m of notes and adds US$500m of deal cash/compute; excess-cash buybacks cut shares from 865.0m in FY28E to 836.8m in FY29E.
Discounted cash flow values PANW at US$162 a share, 12% below our US$184 peer cash-flow cross-check
Source: Penmark Research model (Valuation, Scenarios & Thesis tabs)
Source: Penmark Research model (Scenarios tab)
Values in US$ per share.
| 15-yr DCF: SBC-as-cash test (US$m) | Value | Primary SBC-dilution bridge & peer check | Value |
|---|---|---|---|
| DCF parameters & EV (31 Oct 2026) | Primary DCF bridge: SBC as share dilution | ||
| Risk-free / Beta / Equity risk premium | 4.46%/1.05x/4.80% | EV excluding SBC (31 Oct 2026, US$m) | 148,032 |
| Cost of equity (no debt) / Terminal g | 9.50% / 3.50% | Equity ex SBC (+US$7,705m pro forma cash) | 155,737 |
| PV explicit FCF after SBC (FY27E–41E) | 52,721 | PV of future SBC / 31 Oct disc. price | 39,289 / US$338.40 |
| PV terminal value (US$213,619m; 51.5% EV) | 56,023 | Future dilution (116.1m) + base (851.2m) | 967.3m |
| EV, SBC as cash expense (31 Oct 2026) | 108,744 | Primary base DCF (18 Nov; 31 Oct: US$161.00) | US$161.72 |
| Net cash & share bridge (18 Nov 2026) | Peer EV/LTM FCF check & comparison | ||
| Cash (US$9,135m) + Applied Compute (US$500m) | 9,635 | Peer EV/LTM FCF × US$4,268m LTM FCF | 34.43x = 146,946 |
| Less: convertible notes fair value (31 Oct) | (1,930) | Plus: net cash (US$7,205m) / 838.0m shares | 154,151 / 838.0m |
| Equity value (31 Oct), SBC as cash | 116,449 | Peer EV/LTM FCF cross-check (pre-SBC) | US$183.95 |
| Diluted shares (838.00m + 13.24m AI deal) | 851.24m | DCF with SBC excluded (zero dilution) | US$183.77 |
| SBC-as-cash test (31 Oct: US$136.80; 18 Nov) | US$137.41 | Gap (+13.7%) / 18 Nov share price | +US$22.23 / US$339.92 |
Source: Penmark Research model (Valuation, Peers & Methodology tabs). Rolling 31 Oct to 18 Nov 2026 (0.049 yrs) compounds at 9.50% cost of equity.
Why 15-year DCF is primary and P/E or EV/sales fail
Three distortions make static multiples unreliable. Deferred-revenue inflows add US$1,848m, or 12.6% of FY27E sales, before falling to 3.7% by FY41E as growth cools. LTM SBC runs at 15.6% of sales vs 3.9% at Fortinet, distorting pre-SBC multiples while amortisation depresses GAAP profit. CyberArk, Chronosphere and Applied Compute reshape cash flow through FY31E, so our 15-year DCF fades core growth to 3.5% by FY41E.
SBC dilution vs cash downside test & cross-check gap
Our US$183.95 peer check tops US$161.72 base DCF by US$22.23 because EV/LTM FCF ignores SBC. Dropping SBC adds US$22.06 to US$183.77, leaving US$0.18 from working capital and growth fade. Base DCF keeps the SBC tax shield and converts US$39,289m of PV of future SBC into 116.1m shares at US$338.40 (18 Nov discounted to 31 Oct at 9.5%), beating our US$137.41 cash-SBC test only via overpriced grants. Cost of equity (9.50%) is required equity return; terminal growth (3.50%) is perpetual growth post-FY41E.
Probability-weighted value of US$174 rolls forward to our US$190 12-month target, implying 44% downside
Source: Penmark Research model (Valuation & Scenarios tabs, US$/share)
Values in US$ per share.
Source: Penmark Research model (Scenarios tab, value at 18 Nov 2026)
| Scenario / valuation metric | Bear (20%) | Base (55%) | Bull (25%) | Weighted / Target |
|---|---|---|---|---|
| Scenario assumptions tied to confirmed stock drivers | ||||
| FY28E–FY31E platform growth delta vs base | −4.0pp / yr | 14.5%→10.8% | +6.0pp / yr | Scenario-weighted |
| Long-term core non-GAAP operating margin | 32.0% (−6pp) | 38.0% | 41.0% (+3pp) | Scenario-weighted |
| Long-term SBC (% of revenue) / Deferred rev. ratio | 12.0% / 100% | 7.0% / 108% | 5.0% / 112% | Scenario-weighted |
| Applied Compute scale factor (FY29E base = US$600m) | 0.5x (US$300m) | 1.0x (US$600m) | 2.0x (US$1,200m) | Scenario-weighted |
| Present value per share (18 Nov 2026) | US$107.91 | US$161.72 | US$253.08 | US$173.80 |
| Return from US$339.92 to present value (%) | −68.3% | −52.4% | −25.5% | −48.9% |
| 12-month rolled-forward value (×1.095, zero dividend) | US$118.17 | US$177.08 | US$277.13 | US$190.31 |
| 12-month total return vs US$339.92 (sets Sell rating) | −65.2% | −47.9% | −18.5% | −44.0% |
| Multiples at actual share price (US$339.92) vs at our 12-month target (US$190.31) & reverse-DCF check | ||||
| EV / LTM FCF (US$4,268m, pre-SBC) | At US$339.92 price: 65.1x (US$277,648m EV) | At US$190.31 target: 35.7x | ||
| Non-GAAP P/E: FY27E (US$4.16) / FY28E (US$4.72) | At US$339.92 price: 81.7x / 72.0x | At US$190.31 target: 45.7x / 40.3x | ||
| Reverse DCF (one lever solved at US$339.92 vs base) | Implied cost of equity: 6.04% (vs 9.50%) | Implied g: 7.96% | FY28E core: 28.3% | ||
Source: Penmark Research model (Summary, Scenarios, Market Check and Valuation tabs). Reconciles identically to the Page 1 call box (US$190.31 target, −44.0% total return, US$253.08 bull, US$107.91 bear).
Reverse DCF and robustness across eight model tests
Reverse DCF solves what single input US$339.92 needs: 6.04% cost of equity, 7.96% perpetual growth or 28.3% FY28E core growth. Zero of our eight tests alter our Sell call: a 1pt lower or higher discount rate, five-year beta of 0.97, peer-median beta of 1.14, our base case alone, excluding SBC, expensing SBC as cash, and treating deferred revenue as customer debt.
Initial FY28 guidance in August 2027 is the decisive catalyst testing post-patching growth fade
| Date | Event | Penmark expectation vs guide / consensus | Driver & expected impact |
|---|---|---|---|
| 8 Dec 2026 | 2026 Annual Meeting (virtual, 11am PST) | Advisory say-on-pay vote on US$144.5m FY26 NEO pay (94% equity) and governance proposals | M&A & dilution: tests shareholder pushback on 15.6%–18.1% SBC load |
| Mid-Feb 2027 (est.) | FQ2 FY27 results & FY27 guide check | NGS ARR beats US$10.20bn–US$10.22bn guide (+61% y/y); rev beats US$3.53bn–US$3.55bn; EPS beats US$1.01–US$1.03 | NGS ARR driver: +US$5.26/sh bull catalyst (60% prob.; upside to base value) |
| Spring 2027 (FQ3 FY27E) | Applied Compute clearance & close | US$4.5bn all-stock close (~13.2m est. shares at 18 Nov close; ref. price n.d.); ~US$500m cash/compute received; ~US$2.4bn est. capex starts | M&A & dilution: prior deals sold off −5.2% to −7.4% on close/announce |
| Mid-May 2027 (est.) | FQ3 FY27 results (post-CyberArk lap) | First full organic comparison after 11 Feb 2026 CyberArk close; update on emergency AI patching spend | Post-patching growth: +US$1.68/sh if emergency spend holds; −US$6.86/sh if fading |
| Mid-2027 (6–9m window) | Prisma SASE agentic traffic metering | Commercial launch of usage-based SASE metering (~9x y/y agentic traffic); Penmark assumes modest adoption | NGS ARR driver: +US$1.52/sh bull upside (40% prob.) if surcharges stick |
| Aug 2027 (est.) | FQ4 FY27 results & initial FY28 guidance | Penmark models US$17,074m FY28E rev (14.5% core growth) & US$4.72 consolidated EPS vs US$4.89 Street | Primary Sell catalyst: exposes gap vs 28.3% price-implied core growth |
| CY27 FOMC checkpoints | US 10-year yield & CIBR factor moves | Spot 10Y at 5.10% (17 Nov 2026); persistent >4.5% yields pressure 65.1x EV/FCF multiple (1.47x CIBR beta) | Multiple & discount rate: −US$17.54/sh bear risk (40% prob.) on rate stickiness |
Source: 2026 DEF 14A; FQ1 FY27 Form 8-K Ex. 99.1 & Ex. 99.2; LSEG/CNBC & StockAnalysis consensus; Penmark Research model. Quarterly release dates beyond 8 Dec 2026 are expected windows based on reporting history.
Source: FQ1 FY27 Form 8-K; FQ4 FY26 presentation; Penmark Research
| Confirmed stock driver | Next number to watch | Thesis confirmed if | Thesis broken if |
|---|---|---|---|
| NGS ARR & platformisation | FQ2 FY27 NGS ARR (Feb 2027; US$10.20bn–US$10.22bn guide) | Organic ARR growth slows toward 20% in FY28E once CyberArk/Chronosphere lap | Organic ARR compounds >26% through FY29E on agentic SASE monetisation & >122% NRR |
| Post-patching AI growth | FQ3/FQ4 FY27 Network & AI rev. & initial FY28 guide | Core platform growth steps down from 27.6% (FY27E) to ~14.5% in FY28E | Emergency AI security budgets sustain >22% organic core revenue growth in FY28E–FY30E |
| M&A & share dilution | FQ2–FQ3 FY27 SBC % of rev., diluted shares & Applied Compute capex | SBC stays 15%–18% of sales, shares hit ~865m in FY28E, or new stock M&A is signed | SBC drops rapidly below 10% of revenue with zero additional equity-funded acquisitions |
| Multiple & discount rate | US 10Y yield (5.10%) & EV/LTM FCF (65.1x) | EV/LTM FCF compresses toward peer median 34.4x–35.7x as growth normalises | 10Y yields fall below 3.5%, compressing equity discount rates toward ~6.0% |
Source: Company filings; Penmark Research model (Scenarios & Sensitivities tabs).
Upside risks add US$2–5 a share individually, while rate and dilution risks cut up to US$18
| Risk factor & direction relative to our Sell call | Prob. | Value / sh | Mechanism & stock-driver link |
|---|---|---|---|
| Upside risks against our Sell rating (bull-case catalysts that lift fair value or sustain premium multiples) | |||
| FQ2 FY27 NGS ARR beat & second FY27 guide raise | 60% | +US$5.26 | NGS ARR driver: extends beat-and-raise momentum past Feb 2027 |
| Applied Compute scales toward US$1bn ARR by FY29 | 35% | +US$2.47 | M&A driver: open-weight AI adoption adds +US$240m of FY29E revenue above US$600m base |
| AI-enabled attack wave keeps emergency budgets open | 50% | +US$1.68 | Post-patching growth: critical vulnerability wave (7x y/y) extends past CY27 |
| Agentic SASE metering & FTNT / ZS share capture | 40%–45% | +US$1.52 ea. | NGS ARR driver: ~9x agentic SASE traffic converts into metered pricing |
| Combined Bull scenario (all upside levers simultaneously) | 25% | +US$91.37 | Lifts PV from US$161.72 to US$253.08 (US$277.13 in 12m), still below US$339.92 |
| Downside fundamental & valuation risks (reinforcing downside toward our US$107.91 bear case) | |||
| Higher-for-longer rates compress long-duration multiples | 40% | −US$17.54 | Multiple & rate driver: 5.10% 10Y Treasury forces cost-of-equity repricing |
| SBC & share issuance stay elevated (+2pts FY28E SBC) | 55% | −US$10.89 | M&A & dilution: FQ1 SBC hit 18.1% of sales (bear case holds 12% LT SBC vs 7% base) |
| Patching wave fades & AI defence becomes free feature | 40% | −US$6.86 | Post-patching growth: frontier AI defence commoditises within ~2 years |
| Appliance pull-forward reverses / Cortex pricing pressure | 35% / 30% | −US$3.45 / −US$2.10 | Hardware refresh (~10% of rev) cools; CRWD Flex & MSFT bundle SOC |
Source: Penmark Research model (Thesis and Scenarios tabs; unweighted single-catalyst per-share impacts vs US$161.72 base value; probabilities illustrative).
Source: Penmark Research model (Sensitivities, Scenarios & Market Check tabs)
What would break our Sell thesis on the upside
Crowded sentiment or sustained hyper-growth could keep shares elevated. Zero of 56 analysts rate PANW Sell, and short interest is 2.5% of basic shares. Quarterly ARR beats can hold a 60x–70x cash-flow multiple until FY28 slows, as in the 7.4% after-hours jump to US$365.18 on 18 November. Fundamentally, breaking our Sell call requires organic core growth above 22% across FY28E–FY30E, GAAP stock pay below 10% and 10-year yields below 3.5% together. At US$339.92, the stock prices 28.3% FY28E core growth or a 6.04% discount rate.
M&A, regulatory, legal and key-person risks
- Three-way integration. Absorbing CyberArk at US$1.26bn pro forma sales, Chronosphere and US$4.5bn Applied Compute strains execution. Applied Compute still needs regulatory clearance.
- Breach liability. A critical firewall, SASE or identity flaw would hurt customer trust. Filings do not quantify customer indemnities, so our equity bridge makes no deduction.
- Key-person risk. Strategy and deal-making centre on Chair and CEO Nikesh Arora. His October 2026 variable forward covers up to 500,000 shares, or about 23% of his stake, cutting downside exposure through 2029.
Zero Sell ratings across 56 analysts and 2.5% short interest leave crowded institutional positioning
| Holder (13F institutional / DEF 14A beneficial) | Shares (m) | % basic | Q/Q change (m) | Value at US$339.92 (US$m) |
|---|---|---|---|---|
| Vanguard Group (DEF 14A beneficial: 60.79m / 7.4%) | 81.54 | 10.0% | +0.54 (+0.7%) | 27,718 |
| BlackRock, Inc. (DEF 14A beneficial: 49.24m / 6.0%) | 78.19 | 9.6% | +2.43 (+3.2%) | 26,577 |
| State Street Corp. | 37.06 | 4.5% | +0.08 (+0.2%) | 12,598 |
| FMR LLC (Fidelity) | 31.87 | 3.9% | +11.81 (+58.9%) | 10,832 |
| Morgan Stanley | 27.73 | 3.4% | −1.72 (−5.8%) | 9,426 |
| Invesco Ltd. | 27.27 | 3.3% | +1.62 (+6.3%) | 9,269 |
| JPMorgan Chase & Co. | 25.43 | 3.1% | +3.71 (+17.1%) | 8,644 |
| Geode Capital Management / Bank of America | 20.26 / 16.81 | 2.5% / 2.1% | +0.64 / −5.87 | 6,887 / 5,713 |
| Total reported 13F institutional (3,037 filers) | 657.70 | 80.4% | n.d. | 223,565 |
| Directors & executive officers as a group (DEF 14A, 18 Sep) | 4.49 | 0.55% | Arora 2.16m (<1%) | 1,528 |
Source: SEC Form 13F filings, 30 Sep 2026 vs 30 Jun 2026; largest holders shown (818.0m basic shares reference); 2026 DEF 14A as of 18 Sep 2026 (818.44m shares; differs from consolidated 13F affiliates by voting/dispositive authority).
Source: FINRA bi-weekly short-interest reports, to 30 Oct 2026
Source: Barchart via Yahoo Finance, 56 analysts as of 16 Nov 2026
Liquidity, indices, insider filings & supply
Three-month daily turnover of US$2.27bn pairs with steady share supply. PANW sits in the S&P 500, Nasdaq-100 and CIBR ETF with single-class stock and no controlling holder. Short interest fell from 47.75m shares in January 2026 to 20.62m on 30 October as CyberArk merger arbitrage unwound. That equals 3.5 days to cover. President BJ Jenkins sold 56,214 shares for US$19.92m on 2–4 November under a Rule 10b5-1 plan, ending with 1,200 shares on 4 November. CFO Dipak Golechha's 69,389-share filing was tax withholding. Closing Applied Compute in FQ3 FY27 adds about 13.2m shares on our estimate for US$4.5bn in stock.
Source: MarketScreener and Yahoo Finance (55 analysts, 18 Nov 2026); Penmark Research model
Linked annual income statement, cash-flow statement and balance sheet from FY24A to FY31E
| Fiscal year to 31 July | FY24A | FY25A | FY26A | FY27E | FY28E | FY29E | FY30E | FY31E |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8,027 | 9,221 | 11,480 | 14,694 | 17,074 | 19,600 | 22,188 | 24,743 |
| Revenue growth, y/y (%) | 16.5% | 14.9% | 24.5% | 28.0% | 16.2% | 14.8% | 13.2% | 11.5% |
| Non-GAAP operating income | 2,190 | 2,652 | 3,356 | 4,220 | 4,792 | 5,735 | 6,689 | 7,721 |
| Non-GAAP operating margin (%) | 27.3% | 28.8% | 29.2% | 28.7% | 28.1% | 29.3% | 30.1% | 31.2% |
| Less: SBC-related charges | (1,162) | (1,386) | (1,712) | (2,278) | (2,561) | (2,842) | (3,106) | (3,217) |
| Less: intangible amort. & deal items | (344) | (23) | (949) | (1,340) | (1,200) | (1,059) | (967) | (874) |
| GAAP operating income | 684 | 1,243 | 695 | 602 | 1,032 | 1,834 | 2,616 | 3,630 |
| GAAP operating margin (%) | 8.5% | 13.5% | 6.1% | 4.1% | 6.0% | 9.4% | 11.8% | 14.7% |
| Interest, other & note marks | 304 | 353 | (159) | 175 | 442 | 652 | 314 | 355 |
| Income tax benefit / (expense) | 1,590 | (462) | (229) | 49 | (511) | (732) | (804) | (1,005) |
| GAAP net income | 2,578 | 1,134 | 307 | 827 | 963 | 1,754 | 2,126 | 2,980 |
| GAAP / Non-GAAP diluted EPS (US$/sh) | 3.64 / 2.84 | 1.60 / 3.34 | 0.40 / 3.84 | 0.97 / 4.16 | 1.11 / 4.72 | 2.10 / 5.95 | 2.56 / 6.58 | 3.62 / 7.65 |
Source: Audited FY24–FY26 Forms 10-K; FQ4 FY25 & FQ4 FY26 releases; Penmark Research model (Financials tab; continues to FY41E).
| Fiscal year to 31 July | FY24A | FY25A | FY26A | FY27E | FY28E | FY29E | FY30E | FY31E |
|---|---|---|---|---|---|---|---|---|
| GAAP net income | 2,578 | 1,134 | 307 | 827 | 963 | 1,754 | 2,126 | 2,980 |
| Plus: stock-based compensation | 1,075 | 1,295 | 1,774 | 2,278 | 2,561 | 2,842 | 3,106 | 3,217 |
| Plus: depreciation & intangible amort. | 284 | 343 | 855 | 1,438 | 1,579 | 1,701 | 1,784 | 1,797 |
| Deferred revenue, NWC & non-cash items | (679) | 944 | 1,617 | 1,103 | 1,809 | 1,919 | 1,967 | 1,694 |
| Net cash from operating activities | 3,258 | 3,716 | 4,553 | 5,645 | 6,912 | 8,216 | 8,984 | 9,689 |
| Capital expenditure (core + AI compute) | (157) | (246) | (440) | (595) | (1,153) | (1,313) | (1,275) | (982) |
| Free cash flow (company definition) | 3,101 | 3,470 | 4,113 | 5,050 | 5,759 | 6,903 | 7,709 | 8,707 |
| Buybacks, note payoff & cash M&A | (1,177) | (1,054) | (5,663) | (1,915) | (500) | (15,362) | (6,674) | (7,684) |
| Unlevered FCF after SBC (DCF) | n.a. | n.a. | n.a. | 2,519 | 2,844 | 3,546 | 4,355 | 5,209 |
Source: Audited FY24–FY26 Forms 10-K; Penmark Research model. FY27E row nets US$500m buybacks, US$1,915m note payoff and +US$500m Applied Compute cash.
| Period end | FY25A | FY26A | FQ1 FY27A | FY27E | FY28E | FY29E | FY30E | FY31E |
|---|---|---|---|---|---|---|---|---|
| Cash, equivalents & total investments | 8,459 | 7,906 | 9,135 | 11,041 | 16,299 | 7,840 | 8,875 | 9,897 |
| Net working capital (ex-def. rev.) | 4,521 | 5,007 | 4,107 | 5,437 | 6,147 | 6,860 | 7,544 | 8,413 |
| Property & equipment, net | 387 | 523 | 602 | 800 | 1,454 | 2,066 | 2,457 | 2,441 |
| Goodwill, intangibles & other assets | 8,523 | 32,848 | 33,570 | 36,185 | 35,105 | 34,105 | 33,205 | 32,405 |
| Total assets (model operating-netted) | 21,890 | 46,284 | 47,414 | 53,463 | 59,005 | 50,871 | 52,081 | 53,157 |
| Net cash (31 Oct 2026: US$7,205m) | 8,459 | 6,132 | 7,205 | 11,041 | 16,299 | 7,840 | 8,875 | 9,897 |
Source: FY26 10-K; FQ1 FY27 8-K (31 Oct 2026); Penmark Research model. Columns net non-deferred operating liabilities (US$1,686m, US$2,176m and US$1,696m in FY25A, FY26A and FQ1 FY27A); GAAP gross assets were US$23,576m, US$48,460m and US$49,110m.
Quarterly progression, platform KPIs and per-share ratios from FY25A to FY31E
| Quarter ended | FQ4 FY25A | FQ1 FY26A | FQ2 FY26A | FQ3 FY26A | FQ4 FY26A | FQ1 FY27A | FQ2 FY27G |
|---|---|---|---|---|---|---|---|
| Revenue | 2,536 | 2,474 | 2,594 | 3,002 | 3,410 | 3,445 | 3,530–3,550 |
| Revenue growth, y/y (%) | n.d. | n.d. | 14.9% | 31.1% | 34.5% | 39.2% | 36%–37% |
| Network & AI Security revenue | n.d. | 1,904 | 2,025 | 2,094 | 2,331 | n.d. | n.d. |
| Cortex revenue | n.d. | 422 | 431 | 481 | 586 | n.d. | n.d. |
| Idira identity revenue | n.d. | n.a. | n.a. | 278 | 336 | n.d. | n.d. |
| Non-GAAP operating income | 768 | 746 | 785 | 814 | 1,011 | 1,059 | n.d. |
| Non-GAAP operating margin (%) | 30.3% | 30.2% | 30.3% | 27.1% | 29.6% | 30.7% | n.d. |
| GAAP operating income | 497 | 309 | 397 | (183) | 172 | 96 | n.d. |
| SBC-related charges | 372 | 387 | 321 | 517 | 487 | 622 | n.d. |
| Next-Generation Security ARR | 5,580 | 5,850 | 6,330 | 8,130 | 9,100 | 9,730 | 10,200–10,220 |
| Remaining performance obligations (US$bn) | 15.8 | 15.5 | 16.0 | 18.4 | 21.2 | 21.0 | 21.5–21.6 |
| Non-GAAP diluted EPS (US$/sh) | n.d. | n.d. | n.d. | 0.85 | 1.02 | 1.05 | 1.01–1.03 |
Source: Quarterly Forms 8-K Ex. 99.1; FQ4 FY26 presentation; Penmark Research model (FQ2–FQ3 FY25 revenue US$2,257m and US$2,289m; FQ1 FY27A platform split n.d.).
| US$m unless stated | FY25A | FY26A | FY27E | FY28E | FY29E | FY30E | FY31E |
|---|---|---|---|---|---|---|---|
| Network & AI Security revenue | 7,131 | 8,354 | 9,816 | 10,994 | 12,203 | 13,424 | 14,632 |
| Cortex revenue | 1,539 | 1,920 | 2,669 | 3,309 | 4,004 | 4,725 | 5,481 |
| Idira identity revenue | n.a. | 614 | 1,520 | 1,794 | 2,081 | 2,393 | 2,704 |
| Other services / Applied Compute revenue | 551/n.a. | 592/n.a. | 639/50 | 678/300 | 712/600 | 747/900 | 777/1,150 |
| Next-Generation Security ARR (year-end) | 5,580 | 9,100 | 11,603 | 13,923 | 16,429 | 19,058 | n.d. |
| Platformised NRR / >US$10m customers (ex-M&A) | n.d./52 | 120%/78 | n.d. | n.d. | n.d. | n.d. | n.d. |
Source: FQ4 FY26 presentation; company KPI disclosures; Penmark Research model (Idira FY25A–26A pro forma revenue: US$1,040m and US$1,260m).
| Per-share & ratio summary | FY25A | FY26A | FY27E | FY28E | FY29E | FY30E | FY31E |
|---|---|---|---|---|---|---|---|
| Weighted-average diluted shares (m) | 709.0 | 764.0 | 850.1 | 865.0 | 836.8 | 830.5 | 823.5 |
| Non-GAAP EPS (US$): Consol. / Standalone | 3.34/3.34 | 3.84/3.84 | 4.16/4.28 | 4.72/5.01 | 5.95/6.11 | 6.58/6.60 | 7.65/7.55 |
| Consolidated non-GAAP EPS growth, y/y (%) | 17.6% | 15.0% | 8.4% | 13.4% | 26.1% | 10.5% | 16.3% |
| FCF per share: Reported / After SBC (US$/sh) | 4.89/n.a. | 5.38/n.a. | 5.94/2.96 | 6.66/3.29 | 8.25/4.24 | 9.28/5.24 | 10.57/6.33 |
| GAAP ROE (avg) / After-tax ROCE (avg. IC, %) | 17.5%/n.m. | 1.7%/25.3% | 2.7%/15.0% | 2.7%/17.1% | 5.4%/22.5% | 8.1%/29.7% | 12.1%/39.9% |
| Non-GAAP P/E at US$339.92 share price (x) | 101.8x | 88.5x | 81.7x | 72.0x | 57.1x | 51.7x | 44.4x |
| Non-GAAP P/E at our US$190.31 target price (x) | 57.0x | 49.6x | 45.7x | 40.3x | 32.0x | 28.9x | 24.9x |
| FCF yield at US$339.92: Pre-SBC / After SBC | 1.4%/n.a. | 1.6%/n.a. | 1.7%/0.9% | 2.0%/1.0% | 2.4%/1.2% | 2.7%/1.5% | 3.1%/1.9% |
Source: Penmark Research model. After-tax ROCE = non-GAAP EBIT × (1 − cash tax: 22% FY26A, 20% FY27E–28E, 21% FY29E–31E) / avg invested capital (FY25A negative). Dividend yield 0.0%.
Non-GAAP reconciliations, definitions, peer methodology and source notes
| Line item | FY25A | FY26A | FQ1 FY27A | FY27E | FY28E |
|---|---|---|---|---|---|
| GAAP operating income | 1,243 | 695 | 96 | 602 | 1,032 |
| Plus: stock-based compensation-related charges | 1,386 | 1,712 | 622 | 2,278 | 2,561 |
| Plus: intangible amortisation, acquisition & other items | 23 | 949 | 341 | 1,340 | 1,200 |
| Non-GAAP operating income (company definition) | 2,652 | 3,356 | 1,059 | 4,220 | 4,792 |
| Net cash from operating activities less total capex = Free cash flow | 3,470 | 4,113 | 1,842 | 5,050 | 5,759 |
| Plus: M&A cash items & Applied Compute capex = Adjusted FCF | 3,507 | 4,414 | 1,937 | 5,470 | 6,578 |
| NOPAT (after SBC) + D&A − capex + Δdef. rev. − ΔNWC = Unlevered FCF after SBC | n.a. | n.a. | 1,165 | 2,519 | 2,844 |
Source: FY26 Form 10-K; FQ4 FY26 presentation; FQ1 FY27 Form 8-K Ex. 99.1; Penmark Research model.
| Peer / measure | Business model comparability / calculation definition | Mkt cap / Source |
|---|---|---|
| CrowdStrike (CRWD) | Cloud endpoint, SOC (LogScale) & Falcon Flex platform rival | US$233,143m (24.3% g) |
| Fortinet (FTNT) | ASIC firewall, SD-WAN & SASE rival; low-SBC profit benchmark | US$91,540m (22.1% g) |
| Zscaler (ZS) | Pure-play cloud Security Service Edge / SASE rival to Prisma SASE | US$31,126m (25.4% g) |
| Cloudflare (NET) / Okta (OKTA) | Edge Zero Trust & AI inference (NET); cloud identity rival to Idira (OKTA) | US$104,841m / US$31,866m |
| EV / LTM FCF & Non-GAAP P/E | (Market cap − net cash) / pre-SBC LTM FCF; Price / non-GAAP EPS | Model Peers & Summary |
| ROE, ROA & ROCE | GAAP NI / avg equity or net assets; non-GAAP EBIT / avg IC (pre-tax Ex. 9; post-tax Ex. 86) | Derived from model |
Source: Penmark Research model (Peers tab). Peer closes 16 Nov 2026 (before 18 Nov +6% to +12% sector move); PANW 18 Nov close (US$339.92). Check Point (CHKP) statements unavailable.
Glossary of company & sector terms
NGS ARR: Annualised value of cloud and AI subscriptions across Prisma SASE, Cortex, AI Runtime, software firewalls, CyberArk and Chronosphere, at US$9.73bn in FQ1 FY27.
RPO: Contracted unearned plus unbilled revenue, at US$21.0bn in FQ1 FY27.
Platformisation & NRR: Bundling onto Network and AI, Cortex or Idira (~2,280 bundles in FQ3 FY26). Net retention of 120% tracks expansion net of churn.
SASE, XSIAM & Applied Compute: Cloud network security, AI security operations and PANW's pending US$4.5bn open-weight AI acquisition.
Methodology, limitations & data sources
Archetype & basis: Recurring-revenue software; US$ GAAP; fiscal year to 31 July. Model finalised 19 Nov 2026 on a 31 Oct 2026 balance sheet rolled to the 18 Nov 2026 close.
Departures & limits: Our 15-year DCF leads given deferred-revenue fade, stock-pay gaps and M&A. Base dilution uses discounted share price alongside our US$137.41 cash-SBC test; consensus predates 18 Nov. Peer closes are 16 Nov on mixed periods. Applied Compute reference price, indemnities, capped calls, headcount, segment EBIT, Chronosphere sales and end-user share beyond two distributors at 30% of FY26A sales are n.d.
Sources (18–19 Nov 2026): Forms 10-K (10 Sep 2026), DEF 14A (27 Oct 2026), 8-K (1 Sep & 18 Nov 2026), Form 4 & 13F; FINRA (30 Oct 2026); Yahoo Finance; LSEG/CNBC & StockAnalysis; Gartner & IDC.
Analyst certification and important disclosures
Ratings
Ratings are based on the total return from the share price to our 12-month price target, including dividends. The price target is weighted across bull, base and bear scenarios.
| Buy | Total return to price target above +10% |
| Hold | Total return to price target from −10% to +10%, inclusive |
| Sell | Total return to price target below −10% |
We review ratings at each set of results and whenever the facts change materially. A share price can move outside its band before the rating changes, and targets may not be reached.
Analyst certification
The Penmark Team certifies that (1) the views in this report accurately reflect its views about the subject company and its securities, and (2) no part of its compensation was, is or will be directly or indirectly related to the specific ratings, price targets or views in this report.
Contact
Penmark Research
Questions about our research:
research@penmarkresearch.com
All our research and coverage:
penmarkresearch.com
Basis of preparation
This report uses information publicly available up to its publication date. Share prices are closing prices on the trading day before the publication date, unless stated otherwise. Forecasts, valuations and price targets are Penmark Research’s own, and forecast periods are marked E. Sources are shown beneath each exhibit.
Valuation and price targets
Price targets are based on the valuation methods set out in each report and are weighted across bull, base and bear scenarios. The main risks to each rating and price target are described in the report. Penmark Research updates its coverage after each set of results but is not obliged to update a report at any other time.
Independence and conflicts of interest
Penmark Research is independent. It does not provide investment banking, brokerage, market-making or asset management services, does not trade securities, and does not accept payment from any company for research coverage. Companies do not see or review Penmark Research reports before publication.
No member of the Penmark Team holds a long or short position, directly or through derivatives, in the securities of any company Penmark Research covers.
Regulatory status
Penmark Research publishes general, impersonal investment research on a regular basis. It is not registered as an investment adviser with the US Securities and Exchange Commission or any state securities authority, is not a registered broker-dealer and is not a member of FINRA. Penmark Research does not give advice tailored to any person’s circumstances.
Not investment advice or an offer
This report is for information only. It is not personalised investment advice and is not an offer or solicitation to buy or sell any security or other financial instrument. It does not take into account any reader’s objectives, financial situation or needs. Readers should make their own investment decisions and seek independent professional advice where appropriate.
Forward-looking statements and risk
Forecasts, valuations and price targets are estimates based on assumptions that may prove wrong, and they may not be achieved. Opinions are current as of the publication date and may change without notice. Investing in equities involves risk, including the loss of capital. Share prices can be volatile, and past performance is not a reliable indicator of future results.
Data and sources
Company financials, operating data and filings come from company filings, earnings releases and earnings calls. Market data and any consensus estimates come from third-party sources named beneath the relevant exhibit; consensus figures from aggregators are unofficial. Penmark Research does not use other brokers’ research. Third-party data belong to their providers and may not be extracted from this report.
Accuracy and liability
Information is taken from sources believed to be reliable, but Penmark Research makes no representation or warranty as to its accuracy, completeness or timeliness. To the fullest extent permitted by law, Penmark Research accepts no liability for any loss arising from use of this report. Descriptions of litigation and regulatory matters reflect allegations and public records, not findings, unless stated. If a published report is corrected, the corrected version carries an “Updated” date at penmarkresearch.com.
Distribution and access
Penmark Research reports are available to registered users of penmarkresearch.com. Downloads and programmatic access are governed by the Penmark Research subscription terms. This report is not directed at, or intended for, any person in Singapore or India, and access from those countries is blocked. It is not intended for distribution to, or use by, any person in any jurisdiction where that would be contrary to law or regulation or would subject Penmark Research to registration or licensing requirements there.
Copyright and permitted use
© Penmark Research. All rights reserved. Penmark Research is a trade name of Brightriver Labs. Readers may share a link to this report but may not copy, reproduce, redistribute, sell or use its content, including for text and data mining, without written consent. Contact: research@penmarkresearch.com.